Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer
L.N. Abaid, M.A. Rettenmaier, and J.V. Brown Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer J Gynecol Oncol 23 2012 22 27
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study
M.E. Randall, V.L. Filiaci, and H. Muss Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study J Clin Oncol 24 2006 36 44
Stage III endometrial cancer: Analysis of prognostic factors and failure patterns after adjuvant chemotherapy
Y. Aoki, H. Kase, and M. Watanabe Stage III endometrial cancer: Analysis of prognostic factors and failure patterns after adjuvant chemotherapy Gynecol Oncol 83 2001 1 5
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer
A.A. Secord, L.J. Havrilesky, and D.M. O'Malley A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer Gynecol Oncol 114 2009 442 447
A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the sandwich method for high risk endometrial carcinoma
M.A. Geller, J. Ivy, and K.E. Dusenbery A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the sandwich method for high risk endometrial carcinoma Gynecol Oncol 118 2010 19 23
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer
A.A. Secord, L.J. Havrilesky, and V. Bae-Jump The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer Gynecol Oncol 107 2007 285 291
A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): Final report
L.E. Gaspar, K. Winter, and W.I. Kocha A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): Final report Cancer 88 2000 988 995
Cervical Cancer (Version 2.2013). March 1 March 18, 2013
National Comprehensive Cancer Network. Cervical Cancer (Version 2.2013). March 1, 2013. Available at: http://www.nccn.org/professionals/physician-gls/ pdf/cervical.pdf. March 18, 2013.
Leiden University Medical Center Bethesda (MD): National Library of Medicine (US) [cited 2013 Mar 1] http://clinicaltrials.gov/ct2/show/NCT00411138 NLM Identifier: NCT00411138. March 18, 2013
Leiden University Medical Center. Randomized phase III comparing concurrent chemoradiation and adjuvant chemotherapy with pelvic radiation alone in high risk and advanced stage endometrial carcinoma: PORTEC-3. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2006- [cited 2013 Mar 1]. Available at: http://clinicaltrials.gov/ct2/show/ NCT00411138 NLM Identifier: NCT00411138. March 18, 2013.
Gynecologic Oncology Group [Internet]. Bethesda (MD): National Library of Medicine (US) [cited 2013 Mar 1] http://clinicaltrials.gov/ct2/show/NCT00807768 NLM Identifier: NCT00807768. March 18, 2013
Gynecologic Oncology Group. A Phase III Trial Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2008- [cited 2013 Mar 1]. Available at: http://clinicaltrials.gov/ct2/show/ NCT00807768 NLM Identifier: NCT00807768. March 18, 2013.
Gynecologic Oncology Group [Internet]. Bethesda (MD): National Library of Medicine (US) [cited 2013 Mar 1] http://clinicaltrials.gov/ct2/show/NCT00942357 NLM Identifier: NCT00942357. March 18, 2013
Gynecologic Oncology Group. A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2009- [cited 2013 Mar 1]. Available at: http://clinicaltrials. gov/ct2/show/NCT00942357 NLM Identifier: NCT00942357. March 18, 2013.